Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose

The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy

(2015) Nicola Coppola et al.   BMC INFECTIOUS DISEASES

The long-term efficacy, 13–23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China

(2015) Feng Wang et al.   VACCINE

Screening for Hepatitis B Virus Infection in Adolescents and Adults: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation

(2014) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Hepatitis B Virus Antibody Levels 7 to 9 Years after Booster Vaccination in Alaska Native Persons

(2014) James W. Keck et al.   Clinical and Vaccine Immunology

Chronic Hepatitis B Virus Infection

(2013) Brian J. McMahon   MEDICAL CLINICS OF NORTH AMERICA

Observational Study of Vaccine Efficacy 24 Years after the Start of Hepatitis B Vaccination in Two Gambian Villages: No Need for a Booster Dose

(2013) Maimuna Mendy et al.   PLoS One

Minimization of hepatitis B infection by a 25-year universal vaccination program

(2012) Yen-Hsuan Ni et al.   JOURNAL OF HEPATOLOGY

Antibody persistence and the effect of a booster dose given 5, 10 or 15years after vaccinating preadolescents with a recombinant hepatitis B vaccine

(2012) Vladimir Gilca et al.   VACCINE

Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers

(2012) Yong Poovorawan et al.   Human Vaccines & Immunotherapeutics

Chronic hepatitis B: Update 2009

(2009) Anna S. F. Lok et al.   HEPATOLOGY

Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22‐Year Follow‐Up Study and Response to a Booster Dose

(2009) Brian J. McMahon et al.   JOURNAL OF INFECTIOUS DISEASES